Article · 29 Dec 2025
Review articlePublished 26 Jun 2020
A Review on LBA and LC-MS Platforms for Supporting Large Molecule Pharmacokinetics Bioanalysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Over the past ten years, the global market for large molecule therapeutics has rapidly grown for the treatment of a variety of diseases. LBA and LC-MS are two platforms widely used in pharmacokinetic bioanalysis. In this review, we compare LBA and LC-MS and summarize their strengths and limitations. Strategies for platform selection are provided according to the study purpose, study phase, analyte types, assay requirements and other factors.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Xiaolong Zhang”
- BylineArticles whose byline prints “Linglong Zou”
- BylineArticles whose byline prints “Weiping Shao”
- BylineArticles whose byline prints “Zhongping Linandet al.”
